Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Gilead Sciences, Inc. (GILD) To Go Ex-Dividend on September 15th
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
The Manufacturers Life Insurance Company Sells 148,344 Shares of Gilead Sciences, Inc. $GILD
Bullseye Investment Management LLC Takes Position in Gilead Sciences, Inc. $GILD
Gilead Wins Appeals Court Ruling Blocking Imported HIV Drug Sales
16,506 Shares in Gilead Sciences, Inc. $GILD Bought by Bullseye Investment Management LLC - Stock Observer
Best Medical Stocks To Research - September 11th - Daily Political
Baird Financial Group Inc. Grows Holdings in Gilead Sciences, Inc. $GILD
RBC Capital Keeps Their Hold Rating on Gilead Sciences (GILD)
Gilead Sciences Sees Sunlenca Launch Fueling Long-Term HIV Growth
Tidal Investments LLC Raises Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Acquired by National Pension Service
112,886 Shares in Gilead Sciences, Inc. $GILD Purchased by Engineers Gate Manager LP - Zolmax
Gilead Sciences Eyes HIV, Oncology Catalysts as Pipeline Enters Execution Mode - Stock Observer
Triple Negative Breast Cancer Market to Reach Significant Growth by 2036, Driven by Advancements in Immunotherapy, Targeted Therapies, and Next-generation Treatment Approaches | DelveInsight | ABNewswire
Promising Medical Stocks To Research - September 9th - Markets Daily
Sofinnova Investments Announces the Appointment of Dr. Merdad Parsey as Executive Partner | Morningstar
NewEdge Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights
Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program With Gilead | Morningstar
Arizona State Retirement System Raises Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences, Inc. $GILD Shares Purchased by Groupe la Francaise
California State Teachers Retirement System Has $30.47 Billion Stake in Gilead Sciences, Inc. $GILD
Bixlenvo Gives Gilead a New HIV Growth Path. How Large is the Market?
Promising Biotech Stocks To Consider - September 7th - Zolmax
Gilead Sciences, Inc. $GILD Holdings Raised by HighTower Advisors LLC
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $130.42 Million Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences (NASDAQ:GILD) Stock Rating Lowered by Wall Street Zen - Daily Political
Medical Stocks To Follow Now - September 6th
Saudi Central Bank Acquires 41,091 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Downgraded to Hold Rating by Wall Street Zen - Zolmax
Saudi Central Bank Grows Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?
Gilead Sciences (NASDAQ:GILD) Lowered to Hold Rating by Wall Street Zen
Will New HIV and Oncology Approvals Redefine Gilead Sciences' (GILD) Treatment Platform Narrative?
Kymera Therapeutics (KYMR) Up 10.2% Since Last Earnings Report: Can It Continue?
Top Medical Stocks To Consider - September 4th - Daily Political
NEOS Investment Management LLC Has $120.08 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer
Why Is Gilead (GILD) Up 13.6% Since Last Earnings Report?
Is Gilead Sciences Stock Outperforming the S&P 500?
Nykredit A S Makes New $177.13 Million Investment in Gilead Sciences, Inc. $GILD
iSAM Funds UK Ltd Buys New Stake in Gilead Sciences, Inc. $GILD
B. Metzler seel. Sohn & Co. AG Boosts Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences Q1 EPS Estimate Raised by Zacks Research - Daily Political
iSAM Funds UK Ltd Makes New $2.02 Million Investment in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock
ITOC, PTHL Deadline Alert: Levi & Korsinsky Reminds iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) (ITOC, PTHL) Investors of Securities Class Action Deadline on September 29, 2026 | Morningstar
Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?
Gilead Sciences (NASDAQ:GILD) Raised to "Strong-Buy" at Zacks Research
Gilead takes a 'different' approach to reaching the Black community with new HIV campaign
Gilead Sciences (NASDAQ:GILD) Upgraded by Zacks Research to "Strong-Buy" Rating - Stock Observer
Can Bixlenvo Unlock New Growth for Gilead's HIV Business?
Wall Street Analysts See Gilead (GILD) as a Buy: Should You Invest?
Erste Group Bank Comments on Gilead Sciences FY2026 Earnings
Railway Pension Investments Ltd Cuts Position in Gilead Sciences, Inc. $GILD - Zolmax
Railway Pension Investments Ltd Sells 7,769 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Analysts
FY2026 EPS Estimate for Gilead Sciences Increased by Analyst - Stock Observer
Best Biotech Stocks Worth Watching - August 31st - Daily Political
Headlands Technologies LLC Buys Shares of 49,478 Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Quantitative Investment Management LLC - Stock Observer
Promising Medical Stocks To Consider - August 30th
Promising Pharmaceutical Stocks Worth Watching - August 30th - Daily Political
Hennessy Advisors Inc. Raises Stake in Gilead Sciences, Inc. $GILD
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Position in Gilead Sciences, Inc. $GILD
Van ECK Associates Corp Sells 488,138 Shares of Gilead Sciences, Inc. $GILD
Flputnam Investment Management Co. Sells 67,582 Shares of Gilead Sciences, Inc. $GILD
Nissay Asset Management Corp Japan Has $46.88 Million Position in Gilead Sciences, Inc. $GILD - Markets Daily
Wellington Management Group LLP Sells 838,308 Shares of Gilead Sciences, Inc. $GILD
Royal London Asset Management Ltd. Lowers Position in Gilead Sciences, Inc. $GILD
Pharmaceutical Stocks To Add to Your Watchlist - August 29th - Daily Political
Best Biotech Stocks To Research - August 29th - Daily Political
Braun Stacey Associates Inc. Takes Position in Gilead Sciences, Inc. $GILD
Wellington Management Group LLP Has $1.60 Billion Stake in Gilead Sciences, Inc. $GILD - Stock Observer
Braun Stacey Associates Inc. Invests $12.96 Million in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
Gilead Sciences Inc. (GILD) Stock Price, News, Earnings & Company Profile
Glenview Trust Co Makes New $26.78 Million Investment in Gilead Sciences, Inc. $GILD
Empowered Funds LLC Purchases 30,382 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Equitable Holdings Inc. Decreases Stake in Gilead Sciences, Inc. $GILD - Stock Observer
Empowered Funds LLC Acquires 30,382 Shares of Gilead Sciences, Inc. $GILD
Dearborn Partners LLC Makes New $9.74 Million Investment in Gilead Sciences, Inc. $GILD
Proficio Capital Partners LLC Purchases Shares of 4,405 Gilead Sciences, Inc. $GILD - Stock Observer
Glenview Trust Co Grows Stake in Gilead Sciences, Inc. $GILD - Daily Political
FDA Approves Gilead Sciences' Bixlenvo for Certain Adults With HIV | Morningstar
Anthony Welters Sells 18,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock
Gilead (GILD) Stock Looks Undervalued After A 147% Five Year Run
US FDA approves Gilead's once-daily combination pill for HIV treatment - Yahoo News Canada
Gilead Sciences (GILD) Wins EU Trodelvy Approval, Is The Stock Fully Priced?
17,586 Shares in Gilead Sciences, Inc. $GILD Purchased by Strategic Global Advisors LLC - Zolmax
Strategic Global Advisors LLC Acquires Shares of 17,586 Gilead Sciences, Inc. $GILD
Gilead news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
